ImageneBio, Inc. (IMA)

ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $66.33 million. The enterprise value is -$65.26 million.

Market Cap	66.33M
Enterprise Value	-65.26M

Important Dates

The next estimated earnings date is Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

ImageneBio has 11.18 million shares outstanding. The number of shares has increased by 148.16% in one year.

Current Share Class	10.65M
Shares Outstanding	11.18M
Shares Change (YoY)	+148.16%
Shares Change (QoQ)	+20.83%
Owned by Insiders (%)	1.56%
Owned by Institutions (%)	20.79%
Float	6.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	83.89
Forward PS	n/a
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.49, with a Debt / Equity ratio of 0.02.

Current Ratio	12.49
Quick Ratio	12.16
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.91% and return on invested capital (ROIC) is -42.46%.

Return on Equity (ROE)	-68.91%
Return on Assets (ROA)	-35.86%
Return on Invested Capital (ROIC)	-42.46%
Return on Capital Employed (ROCE)	-34.18%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$53,333
Profits Per Employee	-$3.49M
Employee Count	15
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-350,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5.94
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.77
Average Volume (20 Days)	1,000,073

Short Selling Information

The latest short interest is 387,034, so 3.46% of the outstanding shares have been sold short.

Short Interest	387,034
Short Previous Month	378,159
Short % of Shares Out	3.46%
Short % of Float	6.18%
Short Ratio (days to cover)	10.26

Income Statement

In the last 12 months, ImageneBio had revenue of $800,000 and -$52.40 million in losses. Loss per share was -$9.64.

Revenue	800,000
Gross Profit	800,000
Operating Income	-48.45M
Pretax Income	-45.70M
Net Income	-52.40M
EBITDA	-48.05M
EBIT	-48.45M
Loss Per Share	-$9.64

Balance Sheet

The company has $135.35 million in cash and $2.98 million in debt, with a net cash position of $132.37 million or $11.83 per share.

Cash & Cash Equivalents	135.35M
Total Debt	2.98M
Net Cash	132.37M
Net Cash Per Share	$11.83
Equity (Book Value)	133.14M
Book Value Per Share	11.91
Working Capital	129.05M

Cash Flow

Operating Cash Flow	-47.84M
Capital Expenditures	n/a
Depreciation & Amortization	399,000
Net Borrowing	15.00M
Free Cash Flow	-47.84M
FCF Per Share	-$4.28

Margins

Gross Margin	100.00%
Operating Margin	-6,056.38%
Pretax Margin	-5,712.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-148.16%
Shareholder Yield	-148.16%
Earnings Yield	-78.07%
FCF Yield	-71.29%

Analyst Forecast

The average price target for ImageneBio is $16.00, which is 169.82% higher than the current price. The consensus rating is "Hold".

Price Target	$16.00
Price Target Difference	169.82%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	91.69%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ImageneBio has an Altman Z-Score of 1.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.05
Piotroski F-Score	2